Ibuprofen And Diphenhydramine Citrate (Ibuprofen and Diphenhydramine Citrate)
Aurobindo Pharma Limited · tablet, coated · NDC 59651-692
Ibuprofen And Diphenhydramine Citrate is a medicine made available by Aurobindo Pharma Limited, on the U.S. market since May 2022. Its listing category is "DRUG FOR FURTHER PROCESSING". Listing is not the same as FDA approval. A listing proves the product exists; it does not prove that a particular pack is genuine, so compare yours with the official description below.
Recalls of this product
No FDA recalls are recorded for NDC 59651-692. Recalls are listed in FDA enforcement reports from 2004 onward.
Show as table
| Item | Value (reports) |
|---|---|
| Drug ineffective | 2,823 |
| Pain | 1,964 |
| Nausea | 1,806 |
| Headache | 1,740 |
| Fatigue | 1,423 |
| Dizziness | 1,227 |
| Vomiting | 1,092 |
| Anxiety | 1,072 |
| Drug hypersensitivity | 1,047 |
| Diarrhoea | 939 |
These counts are reports, not proof that the medicine caused the problem. Popular medicines get more reports simply because more people take them. They are useful for spotting what to watch for, not for comparing medicines.
Official listing
Active ingredients
Packages (1)
The last part of the NDC identifies the pack size. Your box should show one of these.
Think your pack is fake?
Stop taking it, keep the pack and receipt, and show it to a pharmacist. In the U.S., report it to FDA MedWatch; elsewhere, to your national medicines regulator. How to spot a fake medicine.
Source: openFDA (U.S. Food and Drug Administration) drug directory, labels, enforcement reports and FAERS, retrieved Nov 8, 2026. The FDA notes this data should not be relied on alone for medical decisions. Not medical advice.